Anzeige
Mehr »
Login
Mittwoch, 27.10.2021 Börsentäglich über 12.000 News von 675 internationalen Medien
Heute im Fokus: InnoCan Pharma! Steht die nächste bahnbrechende News vor der Tür?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3CSPR ISIN: US71715X2036 Ticker-Symbol: EFYA 
Tradegate
26.10.21
21:53 Uhr
2,780 Euro
+0,420
+17,80 %
1-Jahres-Chart
PHARMACYTE BIOTECH INC Chart 1 Jahr
5-Tage-Chart
PHARMACYTE BIOTECH INC 5-Tage-Chart
RealtimeGeldBriefZeit
2,5802,82026.10.

Aktuelle News zur PHARMACYTE Aktie

  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
16.09.Why Are PharmaCyte Shares Moving Higher On Thursday?7
16.09.PharmaCyte up 10% on positive biocompatibility study results for CypCaps5
PHARMACYTE Aktie jetzt für 0€ handeln
14.09.PharmaCyte Biotech, Inc. - 10-Q, Quaterly Report5
09.09.After Nasdaq Uplisting, PharmaCyte Biotech Looks Ready to Rumble13
09.09.Why Is PharmaCyte Biotech Stock Moving Higher In Premarket Thursday?7
09.09.Pre-market Movers: HGEN, PMCB, CRDF, HLBZ, LULU.291OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Thursday's pre-market trading (as of 5.25 A.M. EDT).In the GreenPharmaCyte Biotech, Inc. (PMCB) is up over 23% at...
► Artikel lesen
23.08.PharmaCyte Biotech, Inc. - 8-K, Current Report13
21.08.PharmaCyte Biotech: Buy The 'Dump'36
19.08.Mid-Day Market Update: Macy's Jumps After Q2 Results; PharmaCyte Biotech Shares Drop18
19.08.Sonnet BioTherapeutics, Ensysce Biosciences leads healthcare gainers; PharmaCyte Biotech, Ontrak among major losers90
19.08.PharmaCyte Biotech plunges on $70M capital raise program announcement28
18.08.5 Top Stock Gainers for Wednesday: Lowe's, ViacomCBS and PharmaCyte Biotech13
18.08.PharmaCyte Biotech more than doubles in value after NASDAQ uplisting17
18.08.PharmaCyte Biotech Stock Skyrockets as CEO Spells Out Plans19
18.08.PMCB Stock: 14 Things to Know About PharmaCyte Biotech as Shares Skyrocket14
13.08.PMCB Stock: 2 Big Reasons PharmaCyte Biotech Is Soaring 70% Today22
10.08.PharmaCyte Biotech uplisted to Nasdaq, prices $15M offering18
12.07.PharmaCyte Biotech to reverse split shares 1:1,50030
10.07.PharmaCyte Biotech Announces Reverse Stock Split260LAGUNA HILLS, Calif.--(BUSINESS WIRE)--PharmaCyte Biotech, Inc. (OTCQB: PMCB) (PharmaCyte or Company), a biotechnology company focused on developing cellular therapies for cancer and diabetes using...
► Artikel lesen
19 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,6